Medicines management intervention in people with dementia (V2)

  • Research type

    Research Study

  • Full title

    A feasibility study of an intervention to improve medicines management for people with dementia in primary care in Northern Ireland

  • IRAS ID

    248050

  • Contact name

    Carmel M. Hughes

  • Contact email

    c.hughes@qub.ac.uk

  • Sponsor organisation

    Queen's University Belfast

  • Duration of Study in the UK

    0 years, 3 months, 25 days

  • Research summary

    People with dementia (PWD) have unique medication needs compared with the general older population, due to their impaired cognition and communication skills. It is widely acknowledged that carers can play a key role in helping people with dementia to manage their medications. In addition, the challenges faced by this patient population may influence how doctors prescribe for them. There has been limited research on prescribing, review, administration and adherence to medicines (all parts of medicines management) in PWD, particularly for those living at home and managed within primary care. The aim of this study is to test the feasibility of a plan (intervention) to improve medicines management for community-dwelling people with dementia in Northern Ireland.

    This current study is the third phase of a three-phase study. The first phase involved conducting an observational study to identify the prevalence of potentially inappropriate prescribing among PWD in primary care in Northern Ireland. In the second phase, qualitative methodology was used, which involved conducting semi-structured interviews with PWD and their carers, GPs and community pharmacists. Participants were asked to describe their experiences of medicines management, their perceptions of barriers and facilitators to achieving appropriate medicines management, and their views on potential intervention components. Using all the information collected in phases 1 and 2, a plan (intervention) has been developed for how to improve medicines management for community-dwelling PWD. In this final phase, the current study, we will test out this plan in two community pharmacies in Northern Ireland to find out if it works in practice.

  • REC name

    HSC REC A

  • REC reference

    18/NI/0100

  • Date of REC Opinion

    8 Jun 2018

  • REC opinion

    Further Information Favourable Opinion